Ginkgo bioworks announces participation in 40th annual j.p. morgan healthcare conference

Boston , jan. 5, 2022 /prnewswire/ -- ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, announced today that co-founder and ceo jason kelly is scheduled to participate in a presentation at the 40th annual j.p. morgan healthcare conference on january 12, 2022 at 3:45 p.m.

DNA Ratings Summary

DNA Quant Ranking